Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors
US8883803B2 · kind B2 · utility
75Cited by
22References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 30, 2011 |
| Grant date | Nov 11, 2014 |
| Priority date | — |
| Expiry date | Jul 16, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K33/243
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are irreversible Btk inhibitor compounds, and methods for using such irreversible inhibitors in the treatment of diseases and disorders characterized by the presence or development of solid tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.